One of the great failures of MS research has been the inability to find an effective treatment for people with progressively disabling disease. This progression can be either a steady worsening of disability from the outset (called primary-progressive, or PPMS), or after an initial period of relapsing-remitting MS (called secondary-progressive, or SPMS). One reason for […]